TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Prevalence of mild cognitive impairment and dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Trajectory of cognitive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Caregiver outcomes
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Average Number of Lymph Nodes Identified Intraoperatively Per Subject
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Subject Localization Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in Dermatophot score on skin deterioration and spider veins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Frequency of behavioral response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of DMOT4039A
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended Phase 2 Dose (RP2D) of DMOT4039A
Endpoint domain: Adverse events/effects
Primary endpoint: detection of intracellular staphylococci
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: rate of localisation of intracellular staphylococci
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Shoulder Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucagon treatment success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the curve (AUC) of the study drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Phenylalanine Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of unintended pregnancies after 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Number of Adverse Events per patient
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Change in Schirmer's Test Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10meter Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6min Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed-Up-and-Go Test (TUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Advanced Walking Skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for Gonal-f® Pen device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disease Activity Index (DAI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in dimension of ascending aorta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Student alcohol and drug behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients' eyes that are absent of subretinal fluid (SRF) and intra-retinal fluid (IRF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Mean change in visual acuity (VA) under clinic specific routine treatment schemes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morphological CNV-Changes under clinic specific routine treatment schemes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bacterial counts on blood agar plates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Response rate of VTD induction Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Markers of Other Thrombophilia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline in the score of the Early Social Communication Scales (ESCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the score of a semi-structured social imitation task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the score of the Brief Observation of Social Communication Change (BOSCC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in GMFM-88 Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days staying in the pediatric ward
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: PK-(T½)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PK-(Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAMIS score of treated hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Evaluation Inventory-Short Form (TEI-SF)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Client Satisfaction Questionnaire (CSQ-8)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Completion of Survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decrease in left ventricular ejection fraction (LVEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Inattention, impulsivity and hyperactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absolute change in wet weight of ostomy output or diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes on the Short Beck Depression Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of hemi-diaphragmatic paresis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Onset time of hemi-diaphragmatic paresis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Volume of UI leaked
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Annual Rate of Change in Aortic Root Body-surface-area-adjusted Z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Activation of immune response against insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: degree of subjective anxiety post CO2-challenge
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: difference in degree of anxiety pre- and post CO2-challenge
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area Under the Concentration-time Curve (AUC) From Time Zero to Infinity (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent Terminal Elimination Half-Life (t1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Units of blood products used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in internal anal sphincter pressure from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time for internal anal sphincter pressure to return to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic Prostatitis Symptom (NIH-CPS) questionnaires score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum Concentration (Cmax) of Dabrafenib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Real Progression Free Survival (rwPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Real-World Tumor Response (rwTR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Image quality of knee joint imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Image accuracy of knee joint imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability due to back pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in TH2 cell cytokine secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of retentional and inflammatory lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Frequency and Severity of Dose-Limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Serum Concentration Versus Time Curve (AUC [0-tau])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complications until 30 days after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: T-Wave Alternans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Functional Outcome (mRS(0-1))
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in shoulder pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Steady-state pharmacokinetics area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady-state pharmacokinetics maximum concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady-state pharmacokinetics time to reach maximum concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean maximum Standardized Uptake Value (SUVmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean maximum Standardized Uptake Value (SUVmax-ave)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median incontinence score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Technical Success at Exit From the Cath Lab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of MR Grade 2 (+) or Greater
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mitral Valve Gradient (MVG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Central Line-associated Bloodstream Infections (CLABSI) Events
Endpoint domain: Adverse events/effects
Primary endpoint: Durable Objective Response Rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants With Serious Adverse Drug Reactions (SADR), Serious Adverse Events (SAEs) or Events of Medical Interest (EMIs)
Endpoint domain: Adverse events/effects
Primary endpoint: levels of GM-CSF in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency/severity of adverse and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in respiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Diagnostic accuracy of GRASP AB-MRI temporal kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: safety of transendocardial injection
Endpoint domain: Adverse events/effects
Primary endpoint: feasibility of transendocardial injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of high opening injection pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity in detection of AF burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Days from enrollment to first alcohol or other drug (AOD) treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Any alcohol or other drug (AOD) treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Days of alcohol or other drug (AOD) treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: live birth date
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients consenting for assessments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: number of shoulder dystocia
Endpoint domain: Adverse events/effects
Primary endpoint: number of Clavicle fracture
Endpoint domain: Adverse events/effects
Primary endpoint: number of Brachial plexus injury
Endpoint domain: Adverse events/effects
Primary endpoint: number of Intracranial haemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: number of Neonatal death
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants experiencing adverse events (AEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with overall, serious, drug-related treatment emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in vital signs - heart rate (HR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in clinical chemistry parameters including Albumin and Total protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Plasma Blood Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in beliefs about the effectiveness of psychotherapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Echo intensity of muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of symptom progression
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of recognized cardiomyopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of initiated ventilation support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Motor task performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Diagnostic accuracy (sensitivity specificity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Response rate
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma Concentration of Tenofovir (TFV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration of Emtricitabine (FTC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration of Elvitegravir (EVG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receipt of a complete survivorship care plan
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: prognostic molecular markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: checklist mean score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in Hemoglobin A1c (HbA1c) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in childhood autism rating scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blue voxel count/whole brain voxel count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of post-op delirium
Endpoint domain: Adverse events/effects
Primary endpoint: Disability outcome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: neonatal neurobehavioral measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Operative time of the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Narcotic Use (mg)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Development of acute gut GvHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Measures of Pain Magnitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased control over brain activation measured using fMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Intrahepatic Progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: variation of lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: variation of pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: heart rate (bpm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Complete Resolution of Anterior Chamber (AC) Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hunger and satiety measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wellness measurements
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Thirst intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum angiotensin converting enzyme level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics parameters (AUC, Cmax, Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radioactivity concentration equivalents in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single dose galeterone concentrations in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Route(s) of elimination of a single [14C]galeterone dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: survival of the patient after start of treatment
Endpoint domain: Mortality/survival
Primary endpoint: Rehospitalisation for heart failure
Endpoint domain: Mortality/survival
Primary endpoint: cognitive outcome measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of 5 Key Words Within 6 Sentence Lists Repeated Correctly
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Words Recognized
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech Spatial Qualities Questionnaire (SSQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Receipt of at least 1 influenza vaccine
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety as assessed by adverse reactions and events
Endpoint domain: Adverse events/effects
Primary endpoint: Response rate for regression of tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Response to Tamoxifen treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: success rate of ambulatory care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breakthrough Pain requiring unscheduled epidural supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Boredom proneness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Observer Reported Outcome (ObsRO) measure of health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Labor progress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mechanical strength of tumor proximal femur or tumor vertebrae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Specificity of Bladder EpiCheck Urine Test Kit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of Bladder EpiCheck Urine Test Kit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effects on the Hemostatic System
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Local relapse within the treated breast
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Technical success of Pantheris catheter treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Limb salvage/wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical healing of actinic keratoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Tube dislodgment
Endpoint domain: Adverse events/effects
Primary endpoint: units of red blood cells transfused
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of disease flare
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Back-related function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Safety of connection device
Endpoint domain: Adverse events/effects
Primary endpoint: Ease of use of connection device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Annualized Bleed Rate for Treated Bleeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total average number of steps taken per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of IgG4-RD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relapse prediction of IgG4-RD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c recorded
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Passive critical closing pressure (Pcrit)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes